Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B. Pappalardi, Rab K. Prinjha, Kristen Wong et al.|Nature Cancer|2021Cited by 279
Glaucocalyxin A suppresses multiple myeloma progression in vitro and in vivo through inhibiting the activation of STAT3 signaling pathwayMei Li, Zubin Zhang|Cancer Cell International|2021Cited by 10
Design, Synthesis and Biological Evaluation of 6-(Imidazo[1,2-a]pyridin-6-yl)quinazoline Derivatives as Anticancer Agents via PI3Kα InhibitionMei Li, Yanhua Fan|International Journal of Molecular Sciences|2023Cited by 7